'Melanoma metastases' presentation slideshows

Figure 4 Pathological assessment of immune effector cells associated with melanoma brain metastases following ipilimumab treatment. Hodi FS et al . (2008) CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS

165 views • 1 slides

Figure 3 Pathological examination of resected brain metastasis following ipilimumab treatment.

Figure 3 Pathological examination of resected brain metastasis following ipilimumab treatment. Hodi FS et al . (2008) CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS Nat Clin Pract Oncol doi:10.1038/ncponc1183.

115 views • 1 slides

ncponc1183-pf1

Figure 1 Radiographic changes to melanoma metastases in the brain with administration of CTLA-4 blockade. Hodi FS et al . (2008) CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS Nat Clin Pract Oncol doi:10.1038/ncponc1183.

115 views • 1 slides